Innoviva, Inc.: Form 10-K/A for the period ended Dec 31, 2021
Filed with the SEC on Mar 17, 2022 and accepted by EDGAR at Mar 17, 2022, 16:12 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-01-01 to 2021-12-31 | $391.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 12 months2021-01-01 to 2021-12-31 | $576.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2021-01-01 to 2021-12-31 | $375.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2021-01-01 to 2021-12-31 | $19.1m | us-gaap:InterestExpense |
| Income tax | 12 months2021-01-01 to 2021-12-31 | $76.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2021-01-01 to 2021-12-31 | $368.8m | us-gaap:ProfitLoss |
| Diluted EPS | 12 months2021-01-01 to 2021-12-31 | $2.87 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2021-01-01 to 2021-12-31 | $3.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2021-01-01 to 2021-12-31 | 94,310,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2021-01-01 to 2021-12-31 | $363.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2021-01-01 to 2021-12-31 | $0 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2021-01-01 to 2021-12-31 | $0 | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2021-01-01 to 2021-12-31 | $394.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-12-31 | $201.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-12-31 | $313.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-12-31 | $926.4m | us-gaap:Assets |
| Current liabilities | At period end2021-12-31 | $5.8m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2021-12-31 | $394.7m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2021-12-31 | $414.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-22-004088. Last ingested by Listed: Oct 27, 2026, 17:26 ET. Listed shows no prices and gives no investment advice.